+52 55 1827 8370
someramexico@gmail.com
    Afiliarme

Noticias

  1. Inicio
  2. Noticias
Formar parte de Somera

Últimas noticias

Información actualizada y relevante para la comunidad.

Simposio: ESTADO DE LA RADIOONCOLOGÍA EN MÉXICO Noticia

Simposio: ESTADO DE LA RADIOONCOLOGÍA EN MÉXICO

? ¿Cuál es el estado actual de la radiooncología en México? La radiooncología es una pieza clave en el tratamiento contra el cáncer, sin embargo, en México aún enfrenta grandes desafíos: falta de infraestructura, desigualdad en el acceso y escasez de personal especializado. Le invitamos a ver este video donde analizamos el panorama actual de la radiooncología en el país, los principales retos y qué se necesita para mejorar el acceso y la calidad en la atención. ▶️ Mire el video completo aquí: https://www.youtube.com/live/D92FX24hR9M?si=NnsLCILstY9FaJWR #Salud #Oncología #Radiooncología #México #Cáncer #SaludPública #AccesoALaSalud

25-07-2025
SIMPOSIO ALATRO , Capítulo TERAPIA DE PROTONES Noticia

SIMPOSIO ALATRO , Capítulo TERAPIA DE PROTONES

☢️¡Te invitamos al Simposio ALATRO – Capítulo Terapia de Protones! ? 6 de junio 2025 | ? 17:45–19:00 (hora ARG) En el marco del Congreso #PTCOG2025 ?️ Expertos internacionales | Oncología pediátrica | Consensos regionales ? Más info: https://www.alatrolatam.org/simposios #Protonterapia #OncologíaLatAm #ALATRO

06-06-2025
SOMERA en ESTRO 2025: "The training of Radiation Therapists in Latin America." Noticia

SOMERA en ESTRO 2025: "The training of Radiation Therapists in Latin America."

The training of Radiation Therapists in Latin America.

15-04-2025
SOMERA en ESTRO 2025: "Enhancing Radiotherapy Efficiency and Patient Experience Using a Metro Map Framework." Noticia

SOMERA en ESTRO 2025: "Enhancing Radiotherapy Efficiency and Patient Experience Using a Metro Map Framework."

Enhancing Radiotherapy Efficiency and Patient Experience Using a Metro Map Framework.

15-04-2025
SOMERA en ESTRO 2025: "PATIENT REPORTED OUTCOMES RESULTS USING THE EORTC OUT-PATSAT35 RT QUESTIONNAIRE IN PATIENTS UNDERGOING RADIOTHERAPY." Noticia

SOMERA en ESTRO 2025: "PATIENT REPORTED OUTCOMES RESULTS USING THE EORTC OUT-PATSAT35 RT QUESTIONNAIRE IN PATIENTS UNDERGOING RADIOTHERAPY."

PATIENT REPORTED OUTCOMES RESULTS USING THE EORTC OUT-PATSAT35 RT QUESTIONNAIRE IN PATIENTS UNDERGOING RADIOTHERAPY.

15-04-2025
SOMERA en ESTRO 2025: "Sexual dysfunction and quality of life in prostate cancer patients treated with radiotherapy. Analysis in Mexican population." Noticia

SOMERA en ESTRO 2025: "Sexual dysfunction and quality of life in prostate cancer patients treated with radiotherapy. Analysis in Mexican population."

Sexual dysfunction and quality of life in prostate cancer patients treated with radiotherapy. Analysis in Mexican population.

15-04-2025
SOMERA en ESTRO 2025: "Inter-fraction variability of the mesorectum during long-course radiotherapy in rectal cancer." Noticia

SOMERA en ESTRO 2025: "Inter-fraction variability of the mesorectum during long-course radiotherapy in rectal cancer."

Inter-fraction variability of the mesorectum during long-course radiotherapy in rectal cancer.

15-04-2025
SOMERA en ESTRO 2025: #IORT (Intra Operative RadioTherapy) full dose of 21 Gy in breast cancer: single-institutional retrospective analysis in 1011 patients." Noticia

SOMERA en ESTRO 2025: #IORT (Intra Operative RadioTherapy) full dose of 21 Gy in breast cancer: single-institutional retrospective analysis in 1011 patients."

IORT (Intra Operative RadioTherapy) full dose of 21 Gy in breast cancer: single-institutional retrospective analysis in 1011 patients.

15-04-2025
SOMERA en ESTRO 2025: "3D printed applicators in HDR interstitial and surface brachytherapy." Noticia

SOMERA en ESTRO 2025: "3D printed applicators in HDR interstitial and surface brachytherapy."

3D printed applicators in HDR interstitial and surface brachytherapy.

15-04-2025
SOMERA en ESTRO 2025: "Impact of antihistamines type 1 and 2 in disease free survival of breast cancer patients." Noticia

SOMERA en ESTRO 2025: "Impact of antihistamines type 1 and 2 in disease free survival of breast cancer patients."

Impact of antihistamines type 1 and 2 in disease free survival of breast cancer patients.

15-04-2025
SOMERA en ESTRO 2025: "Evaluation of clinical response and toxicity of hypofractionated radiotherapy regimen versus conventional egimen in locally advanced cervical cancer." Noticia

SOMERA en ESTRO 2025: "Evaluation of clinical response and toxicity of hypofractionated radiotherapy regimen versus conventional egimen in locally advanced cervical cancer."

Evaluation of clinical response and toxicity of hypofractionated radiotherapy regimen versus conventional egimen in locally advanced cervical cancer.

15-01-2025
SOMERA en Estro 2025: ""Impact of molecular profile in breast cancer on locoregional recurrence-free survival: comparison of conventional vs. hypofractionated radiotherapy." Noticia

SOMERA en Estro 2025: ""Impact of molecular profile in breast cancer on locoregional recurrence-free survival: comparison of conventional vs. hypofractionated radiotherapy."

"Impact of molecular profile in breast cancer on locoregional recurrence-free survival: comparison of conventional vs. hypofractionated radiotherapy"

15-04-2025
WhatsApp
Logo

Enlaces

cmcro.com.mx amlcc.org cmo.org.mx smeo.org.mx Consenso Mexicano sobre Diagnóstico y Tratamiento del Cáncer Mamario

Enlaces

fucam.org.mx juntoscontraelcancer.mx estro.org teramac.com.mx

Dirección

Durango 209, piso 3, Roma Nte., Cuauhtémoc, 06700 Cuauhtémoc, CDMX

Correo

someramexico@gmail.com

Teléfono

+52 55 1827 8370

Compromiso

Transformando el futuro de la radioterapia y consolidando una red de colaboración que impulse la innovación.

Somera, Todos los derechos reservados.